Sodium Polystyrene Sulfonate
NDC Package 62250-660-23

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Sodium Polystyrene Sulfonate is a medication used to treat a high level of potassium in your blood. Marketed by Belcher Pharmaceuticals, Llc, this product is identified by NDC 62250-660 and is authorized under FDA application ANDA205727.

Identification & Billing

NDC Package Code
62250-660-23
Package Description
454 g in 1 BOTTLE
Product Code
62250-660
11-Digit Billing Format
62250066023
RxNorm Crosswalk
  • RxCUI: 2101899 - sodium polystyrene sulfonate 15 GM Powder for Suspension
  • RxCUI: 2101899 - sodium polystyrene sulfonate 15000 MG Powder for Oral Suspension
  • RxCUI: 2101899 - sodium polystyrene sulfonate 15 to 60 GM Powder for Oral Suspension
  • RxCUI: 2101899 - sodium polystyrene sulfonate 30 to 50 GM Powder for Rectal Suspension
  • RxCUI: 2101899 - sodium polystyrene sulfonate 4.1 MEQ in 1 GM Powder for Oral Suspension

Clinical Specifications

Proprietary Name
Sodium Polystyrene Sulfonate
Dosage Form
-
Usage Information
This medication is used to treat a high level of potassium in your blood. Too much potassium in your blood can sometimes cause heart rhythm problems. Sodium polystyrene sulfonate works by helping your body get rid of extra potassium.

Regulatory & Marketing

Labeler Name
Belcher Pharmaceuticals, Llc
FDA Application #
ANDA205727
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-15-2016
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62250-660-23 identifies a specific commercial package of 454 g in 1 bottle of Sodium Polystyrene Sulfonate, labeled by Belcher Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Belcher Pharmaceuticals, Llc on March 15, 2016. The current certification is valid through December 31, 2024.

What are the primary indications for this medication?

This medication is used to treat a high level of potassium in your blood. Too much potassium in your blood can sometimes cause heart rhythm problems. Sodium polystyrene sulfonate works by helping your body get rid of extra potassium.

How is this Belcher Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62250066023. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62250-660-23
11-Digit CMS (5-4-2)
62250-0660-23

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.